These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 9723864)
1. The D152H mutation found in growth hormone insensitivity syndrome impairs expression and function of human growth hormone receptor but is silent in rat receptor. Esposito N; Wojcik J; Chomilier J; Martini JF; Kelly PA; Finidori J; Postel-Vinay MC J Mol Endocrinol; 1998 Aug; 21(1):61-72. PubMed ID: 9723864 [TBL] [Abstract][Full Text] [Related]
2. Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Duquesnoy P; Sobrier ML; Amselem S; Goossens M Proc Natl Acad Sci U S A; 1991 Nov; 88(22):10272-6. PubMed ID: 1719554 [TBL] [Abstract][Full Text] [Related]
3. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. Duquesnoy P; Sobrier ML; Duriez B; Dastot F; Buchanan CR; Savage MO; Preece MA; Craescu CT; Blouquit Y; Goossens M EMBO J; 1994 Mar; 13(6):1386-95. PubMed ID: 8137822 [TBL] [Abstract][Full Text] [Related]
7. Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site. Wang X; He K; Gerhart M; Jiang J; Paxton RJ; Menon RK; Black RA; Baumann G; Frank SJ Mol Endocrinol; 2003 Oct; 17(10):1931-43. PubMed ID: 12829808 [TBL] [Abstract][Full Text] [Related]
8. A single arginine residue determines species specificity of the human growth hormone receptor. Souza SC; Frick GP; Wang X; Kopchick JJ; Lobo RB; Goodman HM Proc Natl Acad Sci U S A; 1995 Feb; 92(4):959-63. PubMed ID: 7862673 [TBL] [Abstract][Full Text] [Related]
9. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome. Freeth JS; Ayling RM; Whatmore AJ; Towner P; Price DA; Norman MR; Clayton PE Endocrinology; 1997 Jan; 138(1):55-61. PubMed ID: 8977385 [TBL] [Abstract][Full Text] [Related]
10. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein. Iida K; Takahashi Y; Kaji H; Takahashi MO; Okimura Y; Nose O; Abe H; Chihara K J Clin Endocrinol Metab; 1999 Mar; 84(3):1011-6. PubMed ID: 10084588 [TBL] [Abstract][Full Text] [Related]
11. Effect of different growth hormone (GH) mutants on the regulation of GH-receptor gene transcription in a human hepatoma cell line. Deladoëy J; Gex G; Vuissoz JM; Strasburger CJ; Wajnrajch MP; Mullis PE Eur J Endocrinol; 2002 Apr; 146(4):573-81. PubMed ID: 11916628 [TBL] [Abstract][Full Text] [Related]
12. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Ross RJ; Esposito N; Shen XY; Von Laue S; Chew SL; Dobson PR; Postel-Vinay MC; Finidori J Mol Endocrinol; 1997 Mar; 11(3):265-73. PubMed ID: 9058373 [TBL] [Abstract][Full Text] [Related]
13. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation. Yang N; Wang X; Jiang J; Frank SJ Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) insensitivity and insulin-like growth factor-I deficiency in Inuit subjects and an Ecuadorian cohort: functional studies of two codon 180 GH receptor gene mutations. Fang P; Girgis R; Little BM; Pratt KL; Guevara-Aguirre J; Hwa V; Rosenfeld RG J Clin Endocrinol Metab; 2008 Mar; 93(3):1030-7. PubMed ID: 18073295 [TBL] [Abstract][Full Text] [Related]
15. A novel heterozygous T51I mutation of growth hormone receptor is not associated with short stature. Sakurai T; Iida K; Takahashi Y; Kaji H; Takakuwa S; Sumita R; Okimura Y; Chihara K Growth Horm IGF Res; 2002 Dec; 12(6):411-7. PubMed ID: 12423626 [TBL] [Abstract][Full Text] [Related]
16. The GH receptor and GH insensitivity. Ross RJ Growth Horm IGF Res; 1999 Jun; 9 Suppl B():42-5; discussion 45-6. PubMed ID: 10549305 [TBL] [Abstract][Full Text] [Related]
18. Four contiguous amino acid substitutions, identified in patients with Laron syndrome, differently affect the binding affinity and intracellular trafficking of the growth hormone receptor. Wojcik J; Berg MA; Esposito N; Geffner ME; Sakati N; Reiter EO; Dower S; Francke U; Postel-Vinay MC; Finidori J J Clin Endocrinol Metab; 1998 Dec; 83(12):4481-9. PubMed ID: 9851797 [TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) insensitivity syndrome due to a GH receptor truncated after Box1, resulting in isolated failure of STAT 5 signal transduction. Milward A; Metherell L; Maamra M; Barahona MJ; Wilkinson IR; Camacho-Hübner C; Savage MO; Bidlingmaier M; Clark AJ; Ross RJ; Webb SM J Clin Endocrinol Metab; 2004 Mar; 89(3):1259-66. PubMed ID: 15001620 [TBL] [Abstract][Full Text] [Related]
20. Metalloprotease-mediated GH receptor proteolysis and GHBP shedding. Determination of extracellular domain stem region cleavage site. Wang X; He K; Gerhart M; Huang Y; Jiang J; Paxton RJ; Yang S; Lu C; Menon RK; Black RA; Baumann G; Frank SJ J Biol Chem; 2002 Dec; 277(52):50510-9. PubMed ID: 12403792 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]